Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
Sponsored by University of California, Los Angeles
About this trial
Last updated 9 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 13 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- male and female youth age 9 to 14 years with Diagnostic and Statistical Manuel -IV (DSM-IV) ADHD, combined subtype as determined by Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS) and clinical interview
- minimum scores of 12 on both the inattentive and hyperactive/impulsive subscales of the baseline ADHD-Rating Scale (ADHD-RS)S
- Clinical Global Impression- Severity (CGI-S) score at baseline
- no current medications with central nervous system (CNS) affects
- parents able and willing to monitor proper use of the stimulation device and complete all required rating scales.
Exclusion Criteria
- impaired functioning to a degree that requires immediate initiation of ADHD medication in the opinion of the parents and/or investigator; 2) current diagnosis of pervasive developmental disorder or major depression.
- history of lifetime psychosis or mania
- current suicidality
- history of seizure disorder, tic disorder, or head injury with loss of consciousness.